Five Biotech ETFs Posting Strong Second-Halfs: From ALPS Medical Breakthroughs (SBIO) To The SPDR S&P Biotech ETF (XBI)

2016 has been a tough year for the biotech sector, as drug pricing became a very popular topic among politicians and media outlets, which dubbed many of the industry’s practices...

Keep Reading →